| Project/Area Number |
15H06477
|
|---|
| Research Category |
Grant-in-Aid for Research Activity Start-up
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Dermatology
|
|---|
| Research Institution | Kyushu University |
|---|
Principal Investigator |
Tsuji Gaku 九州大学, 大学病院, 講師 (20423551)
|
|---|
| Project Period (FY) |
2015-08-28 – 2017-03-31
|
| Project Status |
Completed (Fiscal Year 2016)
|
| Budget Amount *help |
¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Fiscal Year 2016: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
|---|
| Keywords | 芳香族炭化水素受容体 / 上皮成長因子受容体阻害薬 / 方向族炭化水素受容体 |
|---|
| Outline of Final Research Achievements |
Epidermal growth factor receptor inhibitors (EGFRIs) in the treatment for carcinomas cause acneiform eruption; however, its mechanism remains unknown. Because activation of aryl hydrocarbon receptor (AhR)-nuclear factor erythroid 2-related factor 2 (Nrf2) axis regulates keratinocyte differentiation and sebaceous gland activity, we hypothesized that activation of AhR-Nrf2 axis by EGFRIs might be involved in the development of acneiform eruption.
We administrated gefitinib (GEF) to normal human epidermal keratinocytes (NHEKs) and SEB-1 cells, a human sebocyte cell line. GEF induced up-regulation of CYP1A1 expression in NHEKs and SEB-1 cells, which was enhanced by 6-formylindolo (3,2-b) carbazole (FICZ), an AhR ligand. GEF induced up-regulation of Nrf2 in NHEKs and production of sebeum in SEB-1 cells, which was enhanced by FICZ. Collectively, acceleration of AhR-Nrf2 axis and sebeceous lipogenesis by EGFRIs may be important during acneiform eruption.
|
